Cargando…

The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial

BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Kar-Fu, Gandhi, Mihir, Lam, Amanda Yun Rui, Julianty, Selly, Chia, Alvin Yeow Meng, Tan, Gilbert Choon Seng, Goh, Su-Yen, Ho, Emily Tse Lin, Koh, Angela Fang Yung, Tan, Gavin Siew Wei, Shum, Eugene Jin Wen, Finkelstein, Eric A., Jafar, Tazeen H., Teoh, Yee Leong, van Dam, Rob M., Whitton, Clare, Thumboo, Julian, Bee, Yong Mong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349028/
https://www.ncbi.nlm.nih.gov/pubmed/34362409
http://dx.doi.org/10.1186/s13063-021-05500-5
_version_ 1783735484460040192
author Yeung, Kar-Fu
Gandhi, Mihir
Lam, Amanda Yun Rui
Julianty, Selly
Chia, Alvin Yeow Meng
Tan, Gilbert Choon Seng
Goh, Su-Yen
Ho, Emily Tse Lin
Koh, Angela Fang Yung
Tan, Gavin Siew Wei
Shum, Eugene Jin Wen
Finkelstein, Eric A.
Jafar, Tazeen H.
Teoh, Yee Leong
van Dam, Rob M.
Whitton, Clare
Thumboo, Julian
Bee, Yong Mong
author_facet Yeung, Kar-Fu
Gandhi, Mihir
Lam, Amanda Yun Rui
Julianty, Selly
Chia, Alvin Yeow Meng
Tan, Gilbert Choon Seng
Goh, Su-Yen
Ho, Emily Tse Lin
Koh, Angela Fang Yung
Tan, Gavin Siew Wei
Shum, Eugene Jin Wen
Finkelstein, Eric A.
Jafar, Tazeen H.
Teoh, Yee Leong
van Dam, Rob M.
Whitton, Clare
Thumboo, Julian
Bee, Yong Mong
author_sort Yeung, Kar-Fu
collection PubMed
description BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) trial is a pragmatic trial that aims to compare the effectiveness of a community-based stepwise diabetes prevention program with added financial incentives (intervention) versus the standard of care (control) in reducing the risk of type 2 diabetes over 3 years among overweight or obese individuals with pre-diabetes. METHODS: This is an open-label, 1:1 randomized controlled trial which aims to recruit 846 adult individuals with isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), or both IFG and IGT from Singapore. Intervention arm participants attend 12 group-based sessions (2 nutrition workshops, 9 exercise sessions, and a goal-setting workshop) delivered at community sites (weeks 1 to 6), receive weekly physical activity and nutrition recommendations delivered by printed worksheets (weeks 7 to 12), and receive monthly health tips delivered by text messages (months 4 to 36). From month 6 onwards, intervention arm participants who remain at the highest risk of conversion to diabetes are prescribed metformin. Intervention arm participants are also eligible for a payment/rewards program with incentives tied to attendance at the group sessions and achievement of the weight loss target (5% of baseline weight). All participants are assessed at baseline, month 3, month 6, and every 6 months subsequently till month 36. The primary endpoint is the proportion of participants with diabetes at 3 years. Secondary endpoints include the mean change from baseline at 3 years in fasting plasma glucose, 2-hour plasma glucose, HbA1c, body weight, body mass index, physical activity, and dietary intake. DISCUSSION: The Pre-DICTED trial will provide evidence of the effectiveness and feasibility of a community-based stepwise diabetes prevention program with added financial incentives for individuals with pre-diabetes in Singapore. The study will provide data for a future cost-effectiveness analysis, which will be used to inform policymakers of the value of a nationwide implementation of the diabetes prevention program. TRIAL REGISTRATION: ClinicalTrials.govNCT03503942. Retrospectively registered on April 20, 2018. Protocol version: 5.0 Date: 1 March 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05500-5.
format Online
Article
Text
id pubmed-8349028
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83490282021-08-09 The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial Yeung, Kar-Fu Gandhi, Mihir Lam, Amanda Yun Rui Julianty, Selly Chia, Alvin Yeow Meng Tan, Gilbert Choon Seng Goh, Su-Yen Ho, Emily Tse Lin Koh, Angela Fang Yung Tan, Gavin Siew Wei Shum, Eugene Jin Wen Finkelstein, Eric A. Jafar, Tazeen H. Teoh, Yee Leong van Dam, Rob M. Whitton, Clare Thumboo, Julian Bee, Yong Mong Trials Study Protocol BACKGROUND: Community-based diabetes prevention programs varied widely in effectiveness, and the intervention strategy consisting of lifestyle interventions, stepwise addition of metformin, and financial incentives has not been studied in real-world clinical practice settings. The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) trial is a pragmatic trial that aims to compare the effectiveness of a community-based stepwise diabetes prevention program with added financial incentives (intervention) versus the standard of care (control) in reducing the risk of type 2 diabetes over 3 years among overweight or obese individuals with pre-diabetes. METHODS: This is an open-label, 1:1 randomized controlled trial which aims to recruit 846 adult individuals with isolated impaired fasting glucose (IFG), isolated impaired glucose tolerance (IGT), or both IFG and IGT from Singapore. Intervention arm participants attend 12 group-based sessions (2 nutrition workshops, 9 exercise sessions, and a goal-setting workshop) delivered at community sites (weeks 1 to 6), receive weekly physical activity and nutrition recommendations delivered by printed worksheets (weeks 7 to 12), and receive monthly health tips delivered by text messages (months 4 to 36). From month 6 onwards, intervention arm participants who remain at the highest risk of conversion to diabetes are prescribed metformin. Intervention arm participants are also eligible for a payment/rewards program with incentives tied to attendance at the group sessions and achievement of the weight loss target (5% of baseline weight). All participants are assessed at baseline, month 3, month 6, and every 6 months subsequently till month 36. The primary endpoint is the proportion of participants with diabetes at 3 years. Secondary endpoints include the mean change from baseline at 3 years in fasting plasma glucose, 2-hour plasma glucose, HbA1c, body weight, body mass index, physical activity, and dietary intake. DISCUSSION: The Pre-DICTED trial will provide evidence of the effectiveness and feasibility of a community-based stepwise diabetes prevention program with added financial incentives for individuals with pre-diabetes in Singapore. The study will provide data for a future cost-effectiveness analysis, which will be used to inform policymakers of the value of a nationwide implementation of the diabetes prevention program. TRIAL REGISTRATION: ClinicalTrials.govNCT03503942. Retrospectively registered on April 20, 2018. Protocol version: 5.0 Date: 1 March 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-021-05500-5. BioMed Central 2021-08-06 /pmc/articles/PMC8349028/ /pubmed/34362409 http://dx.doi.org/10.1186/s13063-021-05500-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Yeung, Kar-Fu
Gandhi, Mihir
Lam, Amanda Yun Rui
Julianty, Selly
Chia, Alvin Yeow Meng
Tan, Gilbert Choon Seng
Goh, Su-Yen
Ho, Emily Tse Lin
Koh, Angela Fang Yung
Tan, Gavin Siew Wei
Shum, Eugene Jin Wen
Finkelstein, Eric A.
Jafar, Tazeen H.
Teoh, Yee Leong
van Dam, Rob M.
Whitton, Clare
Thumboo, Julian
Bee, Yong Mong
The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial
title The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial
title_full The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial
title_fullStr The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial
title_full_unstemmed The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial
title_short The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) program: study protocol for a randomized controlled trial
title_sort pre-diabetes interventions and continued tracking to ease-out diabetes (pre-dicted) program: study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349028/
https://www.ncbi.nlm.nih.gov/pubmed/34362409
http://dx.doi.org/10.1186/s13063-021-05500-5
work_keys_str_mv AT yeungkarfu theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT gandhimihir theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT lamamandayunrui theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT juliantyselly theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT chiaalvinyeowmeng theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT tangilbertchoonseng theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT gohsuyen theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT hoemilytselin theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT kohangelafangyung theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT tangavinsiewwei theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT shumeugenejinwen theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT finkelsteinerica theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT jafartazeenh theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT teohyeeleong theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT vandamrobm theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT whittonclare theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT thumboojulian theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT beeyongmong theprediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT yeungkarfu prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT gandhimihir prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT lamamandayunrui prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT juliantyselly prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT chiaalvinyeowmeng prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT tangilbertchoonseng prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT gohsuyen prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT hoemilytselin prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT kohangelafangyung prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT tangavinsiewwei prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT shumeugenejinwen prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT finkelsteinerica prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT jafartazeenh prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT teohyeeleong prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT vandamrobm prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT whittonclare prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT thumboojulian prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial
AT beeyongmong prediabetesinterventionsandcontinuedtrackingtoeaseoutdiabetespredictedprogramstudyprotocolforarandomizedcontrolledtrial